Epstein Secrets

k it was time for him to concede probably, the day after the election, or at the latest, two days after the election." In an interview with CBS' 60 MinutesVi (11/15, 7.02M), Obama was asked about President Trump's claims of widespread election fraud. Obama said, "The President doesn't like to lose and ne

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

k it was time for him to concede probably, the day after the election, or at the latest, two days after the election." In an interview with CBS' 60 MinutesVi (11/15, 7.02M), Obama was asked about President Trump's claims of widespread election fraud. Obama said, "The President doesn't like to lose and ne

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

k it was time for him to concede probably, the day after the election, or at the latest, two days after the election." In an interview with CBS' 60 MinutesVi (11/15, 7.02M), Obama was asked about President Trump's claims of widespread election fraud. Obama said, "The President doesn't like to lose and ne

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying